Federated Hermes’s Standard BioTools LAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-17,001
Closed -$21.8K 2118
2025
Q4
$21.8K Sell
17,001
-11,544
-40% -$15.5K ﹤0.01% 1754
2025
Q3
$37.1K Buy
28,545
+14,523
+104% +$19K ﹤0.01% 1717
2025
Q2
$16.8K Buy
14,022
+14,020
+701,000% +$15.5K ﹤0.01% 1736
2025
Q1
$2 Sell
2
-1
-33% -$1 ﹤0.01% 2049
2024
Q4
$5 Buy
3
+1
+50% +$2 ﹤0.01% 2066
2024
Q3
$4 Buy
+2
New +$4 ﹤0.01% 2052
2023
Q4
Sell
-498
Closed -$1.44K 2123
2023
Q3
$1.44K Buy
+498
New +$1.3K ﹤0.01% 1993
2020
Q2
Sell
-236,532
Closed -$601K 2310
2020
Q1
$601K Buy
+236,532
New +$777K ﹤0.01% 1323
2018
Q1
Sell
-27
Closed -$1K 2202
2017
Q4
$1K Hold
27
﹤0.01% 2117
2017
Q3
$1K Sell
27
-317
-92% -$1.33K ﹤0.01% 2089
2017
Q2
$1K Hold
344
﹤0.01% 2086
2017
Q1
$2K Hold
344
﹤0.01% 2027
2016
Q4
$3K Hold
344
﹤0.01% 1992
2016
Q3
$3K Hold
344
﹤0.01% 1984
2016
Q2
$3K Sell
344
-70,290
-100% -$661K ﹤0.01% 1955
2016
Q1
$570K Buy
70,634
+796
+1% +$5.74K ﹤0.01% 1247
2015
Q4
$755K Buy
69,838
+41,567
+147% +$408K ﹤0.01% 1180
2015
Q3
$229K Buy
+28,271
New +$445K ﹤0.01% 1477

Other funds holding LAB

Federated Hermes's LAB Position: Q1 2026 in Review

Federated Hermes sold out of Standard BioTools (LAB) in Q1 2026, closing a stake of 17,001 shares — an estimated $21.8K sold.

Federated Hermes first reported a position in LAB in Q3 2015 and held it in 18 quarters. The position peaked at $755K in Q4 2015. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

  • Federated Hermes reported no remaining Standard BioTools position as of Q1 2026 after selling out during the quarter.
  • Federated Hermes sold 17,001 Standard BioTools shares in Q1 2026, an estimated $21.8K.
  • Federated Hermes first reported a position in Standard BioTools in Q3 2015 and held it in 18 quarters.
  • Federated Hermes's Standard BioTools position peaked at $755K in Q4 2015.
  • 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.